- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x HJG: 2-{3-[1-(4-chlorophenyl)cyclopropyl][1,2,4]triazolo[4,3-a]pyridin-8-yl}propan-2-ol(Non-covalent)
HJG.2: 19 residues within 4Å:- Chain A: T.108, S.109, L.110, S.154, L.155, A.156, Q.161, I.164, Y.167, L.199, G.200, L.201, A.207, E.210, I.211, I.215
- Chain B: Y.268
- Ligands: NAP.1, HJG.7
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:L.110, A:L.155, A:L.155, A:A.156, A:I.164, A:Y.167, A:Y.167, A:L.201, A:A.207, A:E.210, A:I.211, A:I.215
- Hydrogen bonds: A:A.156, A:Q.161
HJG.7: 17 residues within 4Å:- Chain A: L.155, M.159, Q.161, L.201, I.215, A.217, D.243, S.245, L.247, T.248, L.251
- Chain B: M.260, F.263, S.264, Y.267, Y.268
- Ligands: HJG.2
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.263, B:Y.267, A:L.155, A:L.251
HJG.9: 18 residues within 4Å:- Chain A: Y.268
- Chain B: T.108, S.109, L.110, S.154, L.155, A.156, I.164, Y.167, L.199, G.200, L.201, A.207, E.210, I.211, I.215
- Ligands: NAP.8, HJG.10
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:L.110, B:L.155, B:L.155, B:A.156, B:I.164, B:Y.167, B:Y.167, B:L.201, B:A.207, B:E.210, B:I.211, B:I.215
- Hydrogen bonds: B:A.156, B:Y.167
HJG.10: 17 residues within 4Å:- Chain A: M.260, F.263, S.264, Y.267, Y.268
- Chain B: L.155, M.159, Q.161, L.201, I.215, A.217, D.243, S.245, L.247, T.248, L.251
- Ligands: HJG.9
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:F.263, A:Y.267, B:L.155, B:Q.161, B:L.251
- Hydrogen bonds: B:Q.161
- 7 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 6 residues within 4Å:- Chain A: K.28, G.29, R.32, T.204, E.205, K.222
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:G.29, A:E.205
- Water bridges: A:R.32
- Salt bridges: A:R.32, A:K.222
SO4.4: 2 residues within 4Å:- Chain A: R.50, Q.107
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.50
SO4.5: 3 residues within 4Å:- Chain A: K.237, S.238, E.239
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:S.238, A:S.238, A:E.239
- Water bridges: A:S.238, A:S.238
SO4.6: 1 residues within 4Å:- Chain A: R.32
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.32
SO4.11: 6 residues within 4Å:- Chain B: K.28, G.29, R.32, T.204, E.205, K.222
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:G.29, B:E.205
- Water bridges: B:R.32, B:T.206, B:T.206
- Salt bridges: B:R.32, B:K.222
SO4.12: 2 residues within 4Å:- Chain B: R.50, Q.107
2 PLIP interactions:2 interactions with chain B- Water bridges: B:T.106
- Salt bridges: B:R.50
SO4.13: 3 residues within 4Å:- Chain B: K.237, S.238, E.239
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.238, B:E.239
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, J. et al., Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD-1). ACS Med Chem Lett (2018)
- Release Date
- 2018-12-19
- Peptides
- Corticosteroid 11-beta-dehydrogenase isozyme 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x HJG: 2-{3-[1-(4-chlorophenyl)cyclopropyl][1,2,4]triazolo[4,3-a]pyridin-8-yl}propan-2-ol(Non-covalent)
- 7 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, J. et al., Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD-1). ACS Med Chem Lett (2018)
- Release Date
- 2018-12-19
- Peptides
- Corticosteroid 11-beta-dehydrogenase isozyme 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B